BlackRock Group’s Acceleron Pharma Inc. XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $7.06M | Buy |
276,525
+87,794
| +47% | +$2.24M | ﹤0.01% | 1005 |
|
|
2016
Q3 | $6.83M | Sell |
188,731
-2,313
| -1% | -$83.7K | ﹤0.01% | 1005 |
|
|
2016
Q2 | $6.49M | Sell |
191,044
-129
| -0.1% | -$4.38K | ﹤0.01% | 999 |
|
|
2016
Q1 | $5.05M | Buy |
191,173
+74,285
| +64% | +$1.96M | ﹤0.01% | 1076 |
|
|
2015
Q4 | $5.7M | Buy |
116,888
+846
| +0.7% | +$41.2K | ﹤0.01% | 1058 |
|
|
2015
Q3 | $2.89M | Buy |
116,042
+5,714
| +5% | +$142K | ﹤0.01% | 1296 |
|
|
2015
Q2 | $3.49M | Buy |
110,328
+10,275
| +10% | +$325K | ﹤0.01% | 1273 |
|
|
2015
Q1 | $3.81M | Buy |
100,053
+10,752
| +12% | +$409K | ﹤0.01% | 1205 |
|
|
2014
Q4 | $3.48M | Buy |
89,301
+34,675
| +63% | +$1.35M | ﹤0.01% | 1249 |
|
|
2014
Q3 | $1.65M | Buy |
54,626
+526
| +1% | +$15.9K | ﹤0.01% | 1493 |
|
|
2014
Q2 | $1.84M | Sell |
54,100
-807
| -1% | -$27.4K | ﹤0.01% | 1483 |
|
|
2014
Q1 | $1.9M | Buy |
54,907
+12,807
| +30% | +$442K | ﹤0.01% | 1585 |
|
|
2013
Q4 | $1.67M | Buy |
+42,100
| New | +$1.67M | ﹤0.01% | 1636 |
|